Prospective serial evaluation of myocardial perfusion and lipids during the first six months of pravastatin therapy
- 14 August 2003
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 42 (4) , 600-610
- https://doi.org/10.1016/s0735-1097(03)00767-8
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Resolution of Stress-Induced Myocardial Ischemia During Aggressive Medical Therapy as Demonstrated by Single Photon Emission Computed Tomography ImagingCirculation, 2001
- Cholesterol reduction improves myocardial perfusion abnormalities in patients with coronary artery disease and average cholesterol levelsJournal of the American College of Cardiology, 2000
- The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemiaJournal of the American College of Cardiology, 1999
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Biostatistical AnalysisEcology, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Effect of Short-term Cardiovascular Conditioning and Low-Fat Diet on Myocardial Blood Flow and Flow ReserveCirculation, 1995
- Beneficial Effects of Cholesterol-Lowering Therapy on the Coronary Endothelium in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1995
- Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia.Circulation, 1994